YOLFTbeta
60

Guizhou Yibai Pharmaceutical Co Ltd

600594 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

3.13CNY-0.08 (-2.49%)

Price History

Full chart

Market Stats

Previous Close3.21
Open3.20
Day Range3.11 – 3.21
52-Week Range2.85 – 5.27
Volume15.73M
Market Cap2.88B
P/E (TTM)0.00
Forward P/E30.58
EPS-0.50
Dividend Yield0.00%
Beta0.16
50-Day Avg3.74
200-Day Avg3.86

About

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells novel pharmaceutical products in China. The company offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, gynecological, tonic, oncology, orthopedics, gastroenterology, andrology and urology. Guizhou Yibai Pharmaceutical Co., Ltd. was founded in 1995 and is based in Guiyang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Ya Qi Dou
  • Employees4.83K
  • HeadquartersNo. 220-1, Baiyun Avenue, Guiyang, China, 550008, China
  • Websitehttps://gzcci.com

Leadership

  • Ms. Ya Qi DouVice Chairman, Accounting Supervisor & Deputy GM · b. 1984
  • Mr. Xianti ZengFinancial Director · b. 1974
  • Mr. Zhiwei Wang CPADeputy GM & Director · b. 1970
  • Mr. Jiang XianhongDeputy GM & Secretary to the Board · b. 1985
  • Mr. Zhou YiDeputy General Manager · b. 1970
  • Ms. Jian PuDeputy General Manager · b. 1978
  • Mr. Li Dong WangDeputy General Manager · b. 1981
  • Mr. Hua Wen WangDeputy General Manager · b. 1973

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue276.53M443.78M502.67M631.91M739.37M717.18M1.01B1.15B1.31B1.47B1.90B2.25B2.78B3.16B3.30B3.69B3.81B3.88B3.36B3.41B3.35B2.74B2.82B2.17B1.86B
Growth (%)-+60.48%+13.27%+25.71%+17.01%-3.00%+40.32%+14.67%+13.30%+12.24%+29.70%+18.35%+23.63%+13.36%+4.61%+11.64%+3.28%+1.98%-13.44%+1.55%-1.95%-18.27%+3.12%-22.92%-14.31%
Cost of Revenue161.18M257.65M228.94M190.08M209.71M186.84M257.79M280.58M362.16M335.41M326.99M420.04M503.30M579.88M654.97M885.74M964.74M1.08B734.56M715.91M747.90M814.48M935.74M852.07M751.46M
Gross Profit115.36M186.13M273.73M441.83M529.67M530.34M748.52M873.35M945.24M1.13B1.58B1.83B2.28B2.58B2.65B2.80B2.84B2.81B2.63B2.70B2.60B1.92B1.88B1.32B1.11B
Gross Margin41.72%41.94%54.45%69.92%71.64%73.95%74.38%75.68%72.30%77.14%82.82%81.35%81.93%81.63%80.17%75.98%74.66%72.24%78.14%79.03%77.65%70.22%66.82%60.81%59.66%
Operating Expense78.73M132.33M212.61M375.32M467.79M674.64M678.24M756.64M810.10M912.69M1.27B1.43B1.76B2.05B2.45B2.34B2.38B3.58B2.39B2.38B2.28B2.30B1.75B1.63B1.21B
Operating Income36.62M53.81M61.12M66.51M61.88M-144.31M70.29M116.72M135.14M219.36M310.69M405.50M522.52M524.13M194.54M463.93M466.31M-777.95M238.75M315.94M315.40M-375.97M137.36M-312.25M-93.56M
Operating Margin13.24%12.12%12.16%10.53%8.37%-20.12%6.98%10.11%10.34%14.95%16.32%18.00%18.76%16.60%5.89%12.58%12.25%-20.04%7.10%9.26%9.42%-13.75%4.87%-14.36%-5.02%
EBITDA43.07M66.26M81.13M86.63M106.17M-87.37M138.93M195.78M212.15M277.44M396.15M470.09M584.88M686.81M371.02M659.54M708.59M-530.61M413.03M483.93M495.78M-179.45M346.61M-121.83M-117.07M
EBITDA Margin15.57%14.93%16.14%13.71%14.36%-12.18%13.81%16.97%16.23%18.91%20.81%20.87%21.00%21.75%11.23%17.89%18.61%-13.67%12.29%14.18%14.81%-6.56%12.29%-5.60%-6.28%
Net Income34.05M45.57M51.56M56.34M69.42M-134.52M92.74M98.13M121.81M195.56M265.48M333.27M429.15M478.44M189.38M384.86M387.53M-725.50M141.90M228.76M243.77M-426.39M103.40M-317.22M-329.56M
Net Income Margin12.31%10.27%10.26%8.92%9.39%-18.76%9.22%8.50%9.32%13.33%13.95%14.79%15.41%15.15%5.73%10.44%10.18%-18.68%4.22%6.70%7.28%-15.59%3.67%-14.59%-17.69%
R&D---------8.39M2.16M86.51M146.09M217.40M522.33M443.20M71.40M76.78M118.55M146.00M136.07M126.93M112.15M100.50M84.27M
R&D as % of Total Revenue---------0.57%0.11%3.84%5.25%6.89%15.82%12.02%1.88%1.98%3.53%4.28%4.07%4.64%3.98%4.62%4.52%
Interest Expense3.38M7.06M11.77M2.36M13.51M22.34M29.45M29.90M15.96M22.98M17.71M19.24M23.11M48.63M57.46M63.42M83.47M76.02M52.10M45.56M37.86M40.63M22.68M26.79M23.37M
Interest Expense % of Total Revenue1.22%1.59%2.34%0.37%1.83%3.11%2.93%2.59%1.22%1.57%0.93%0.85%0.83%1.54%1.74%1.72%2.19%1.96%1.55%1.33%1.13%1.49%0.80%1.23%1.25%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets217.81M303.07M455.14M867.80M1.20B987.97M1.14B1.22B1.28B1.56B1.80B2.28B3.20B5.50B5.59B6.59B7.19B6.48B5.62B5.23B5.07B4.87B4.60B4.10B3.44B
Total Liabilities135.18M174.87M274.93M361.10M652.65M562.27M610.24M620.62M571.26M688.82M665.51M731.33M1.27B2.07B2.04B2.40B2.55B2.56B1.89B1.76B1.51B1.68B1.58B1.49B1.17B
Total Equity82.63M128.20M179.76M507.64M556.23M423.44M511.75M579.37M701.18M866.17M1.13B1.54B1.92B3.41B3.54B3.89B4.23B3.46B3.60B3.37B3.50B3.04B2.88B2.49B2.19B
Cash36.61M87.93M61.23M113.66M109.25M132.32M139.30M160.02M188.80M189.92M164.85M192.43M148.69M1.05B1.05B1.03B1.17B550.80M1.02B617.43M379.63M592.36M699.47M521.01M447.13M
Total Debt90.15M98.15M176.65M171.65M321.65M357.65M311.53M255.75M260.20M300.60M249.90M301.50M402.52M760.52M1.05B1.52B1.66B1.51B1.34B1.18B902.95M1.08B863.63M711.35M-
Net Debt53.54M10.22M115.42M57.99M212.40M225.33M172.23M95.73M71.40M110.68M85.05M109.07M253.83M-292.33M2.80M499.22M494.44M959.32M318.41M567.50M523.32M485.44M164.16M190.34M66.93M

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-73.46M92.10M-44.80M17.38M95.77M11.94M189.26M103.88M115.66M277.83M288.01M577.24M541.58M573.68M380.62M681.78M214.30M362.71M366.66M934.21M345.30M377.61M86.87M256.71M
Investing Cash Flow--22.89M-187.63M-164.31M-130.81M-83.09M63.44M-62.37M-2.53M-77.99M-107.82M-267.48M-734.14M-787.93M-935.12M-574.92M-424.39M-356.66M548.43M-427.78M-687.67M-307.78M-115.59M-103.84M-
Financing Cash Flow-749.07K68.82M261.55M132.56M10.39M-69.83M-106.17M35.93M-71.43M-70.72M79.16M13.43M1.19B322.20M239.37M-23.94M-553.29M-333.95M-703.02M-485.01M168.87M-151.69M-159.71M-
Capital Expenditure022.49M169.47M109.40M80.99M17.00M38.97M62.86M44.62M49.66M142.34M209.64M273.48M203.94M288.02M332.53M402.80M321.33M201.28M395.74M447.78M322.92M130.38M96.32M34.99M
Free Cash Flow-50.97M-77.37M-154.20M-63.60M78.77M-27.03M126.40M59.26M66.01M135.49M78.37M303.76M337.65M285.66M48.08M278.98M-107.03M161.44M-29.08M486.43M22.38M247.23M-9.45M221.71M
Dividends Paid-5.78M9.94M12.25M18.20M22.30M24.76M49.15M16.15M48.16M17.62M49.20M78.77M85.23M98.43M73.18M120.34M129.53M65.50M475.16M102.95M49.11M41.18M86.87M28.69M
FCF to OCF-69.38%-84.00%344.19%-365.88%82.25%-226.30%66.78%57.05%57.07%48.77%27.21%52.62%62.34%49.79%12.63%40.92%-49.94%44.51%-7.93%52.07%6.48%65.47%-10.88%86.37%
Dividend Paid to FCF-11.34%-12.85%-7.94%-28.62%28.31%-91.61%38.89%27.26%72.97%13.01%62.78%25.93%25.24%34.46%152.20%43.14%-121.02%40.57%-1633.87%21.16%219.50%16.66%-919.50%12.94%

Earnings

Report DateMar 31, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Mar 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Oct 28, 2013Feb 26, 2014Apr 18, 2014Aug 16, 2014Oct 30, 2014Feb 25, 2015Apr 28, 2015Aug 26, 2015Oct 23, 2015Mar 2, 2016Apr 27, 2016Aug 26, 2016Oct 28, 2016Dec 31, 2016Apr 26, 2017Aug 18, 2017Oct 27, 2017Dec 31, 2017Apr 27, 2018Aug 29, 2018Oct 30, 2018Dec 31, 2018Apr 29, 2019Aug 28, 2019Oct 30, 2019Apr 27, 2020Jul 30, 2020Oct 29, 2020Apr 23, 2021Aug 27, 2021Oct 28, 2021Apr 23, 2022Aug 26, 2022Oct 28, 2022Apr 28, 2023
EPS Estimate---------0.12------0.19-0.200.180.19-0.170.240.36-0.190.150.150.190.130.160.180.110.110.150.15-1.260.06------------
EPS Actual0.020.060.040.080.090.080.040.090.120.130.050.110.130.180.060.120.170.240.070.140.190.220.180.010.120.030.100.120.150.120.130.110.170.090.090.080.04-1.170.080.050.07-0.020.080.090.090.130.16-0.070.100.090.06
Surprise---------8.33%-------10.53%--65.00%-22.22%0.00%-5.88%-95.83%-66.67%--47.37%-20.00%0.00%-36.84%0.00%-31.25%-5.56%-18.18%-18.18%-46.67%-73.33%6.84%33.33%------------
Timing---------Pre-market------After-hours-After-hours-After-hours-After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hoursAfter-hours---------

Key Statistics & Ratios

Market Cap2.88B
Enterprise Value3.14B
Trailing P/E0.00
Forward P/E30.58
Price / Sales1.85
Price / Book1.37
EPS-0.50
Book Value2.69
Revenue (TTM)1.56B
Gross Profit (TTM)865.55M
EBITDA-52.27M
Profit Margin-25.01%
Operating Margin-19.90%
Return on Equity-16.39%
Return on Assets-3.56%
Shares Outstanding791.93M
Shares Float580.25M
Beta0.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.13Jun 8, 2021
20202×
0.30Sep 2, 20200.30Jun 3, 2020
20181×
0.05Jul 2, 2018
20171×
0.06Jul 18, 2017
20161×
0.02Jul 28, 2016
20151×
0.12Jul 16, 2015
20141×
0.06Jul 14, 2014
20131×
0.07Jun 13, 2013
20121×
0.04May 22, 2012
20102×
0.01Oct 15, 20100.03Jun 21, 2010
20082×
0.05Jul 3, 20080.08Jun 16, 2008
20061×
0.02Jun 5, 2006
20052×
0.47Dec 5, 20050.01Jun 9, 2005

Stock Splits

  • Jul 16, 20152:1
  • Oct 15, 20103:2
  • Jul 3, 200813:10
  • Sep 17, 20073:2
  • Jun 5, 200650081:33387
  • Jun 9, 20056:5